Sotera Health vs Tempus AI
Add, change or remove companies; up to four.
KIRAβs take AI analyst
I put Sotera Health and Tempus AI side by side, using each oneβs latest annual report. Here is what stands out:
- Tempus AI is the larger business, with $1.3B of revenue in fiscal 2025 against $1.2B for Sotera Health.
- Tempus AI grew revenue faster (83.4%, against 5.7%).
- Sotera Health turned more of its sales into free cash flow (12.8% FCF margin, against β18.8%).
Who comes out ahead
Of the 6 measures where higher (or lower) is clearly better, how many each company leads.
Sotera Health
SHC
5/6
Net marginFCF marginReturn on equityPiotroski F-scoreShare count change
Tempus AI
TEM
1/6
Revenue growth
Side by side
Best in the row
| Latest fiscal year | SHC FY25 | TEM FY25 |
|---|---|---|
| Size | ||
| Market cap | $5.2B | $13.5M |
| Revenue | $1.2B | $1.3B |
| Free cash flow | $149M | β$239M |
| Net income | $77.9M | β$245M |
| Growth | ||
| Revenue growth | 5.7% | 83.4% |
| 5-year growth | 7.3% | β |
| Share count change | 0.5% | 45.4% |
| Profitability | ||
| Gross margin | 55.5% | β |
| Operating margin | β | β19.9% |
| Net margin | 6.7% | β19.3% |
| FCF margin | 12.8% | β18.8% |
| Return on capital | 6.7% | β |
| Return on equity | 15.4% | β89.5% |
| Balance sheet | ||
| Net debt | $1.9B | β$396M |
| Net debt / EBITDA | β | β |
| Dividends and buybacks | $0.0M | $3.0M |
| Valuation & quality | ||
| P/E | 31.8x | β |
| Piotroski F-score | 7 | 5 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.